# An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD

> **NCT02228655** · EARLY_PHASE1 · TERMINATED · sponsor: **FerruMax Pharmaceuticals, Inc.** · enrollment: 2 (actual)

## Conditions studied

- Anemia in Chronic Kidney Disease

## Interventions

- **DRUG:** FMX-8

## Key facts

- **NCT ID:** NCT02228655
- **Lead sponsor:** FerruMax Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2015-04
- **Final completion:** 2015-07
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Inability to recruit patients meeting eligibilty criteria.
- **Last updated:** 2016-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02228655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02228655, "An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02228655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*